|
|
|
| Clinical Efficacy of Metoprolol Combined with Dopamine in Children with Severe Pneumonia Complicated with Heart Failure |
| LIAO Ni, ZHANG Guoying, XIONG Zihong, et al |
| Chengdu Women's and Children's Hospital, Sichuan Chengdu 610091, China |
|
|
|
|
Abstract Objective: To investigate the clinical efficacy of metoprolol combined with dopamine in the treatment of severe pneumonia complicated with heart failure. Methods: 140 cases of children with severe pneumonia combined with heart failure were selected from June 2015 to December 2016 and randomly divided into the control group and the observation group, 70 cases in each group. Basic supportive therapy and anti-infection treatment, correction of hypovolemia were given to both groups of patients, then equal amount of dopamine was given to both groups via intravenous drip, the observation group was given oral metoprolol treatment on the basis of control group, all the treatment lasted for 7 days. The total effective rate, changes of heart rate, breathing rate and blood oxygen saturation, CK-MB, LDH levels before and after the treatment, improvement time of clinical symptoms and signs were compared between two groups of patients. Results: After treatment, the total efficiency of observation group (92.86%) was significantly higher than that of the control group (74.29%) (P=0.00); the heart rate, respiratory rate, serum CK-MB, LDH levels after treatment were significantly lower than those before treatment, which were significantly lower in the observation group than those of the control group (P<0.05); the blood oxygen saturation of both groups after treatment were significantly higher than those before treatment, which was significantly higher in the observation group than that of the control group (P<0.05); the improvement time of symptoms and signs in observation group were shorter than those of the control group(P<0.05). Conclusion: Metoprolol combined with dopamine could effectively improve the symptoms and signs, shorten the time of clinical symptoms and signs in the treatment of severe pneumonia with heart failure in children.
|
|
|
|
|
|
[1] 王秀云,成建学,杨生梅.酚妥拉明联合多巴胺治疗小儿重症肺炎的临床疗效研究[J].中国医师杂志,2016,18(1):59~61.
[2] 黄妮娜,高晓鹏,章玉丹,等.多巴胺联合酚妥拉明治疗小儿重症肺炎合并心衰疗效研究[J].现代生物医学进展,2017,17(12):2302~2305.
[3] 陈玲.多巴胺联合酚妥拉明对小儿肺炎合并心力衰竭的临床疗效研究以及心肌酶谱的影响[J].临床急诊杂志,2016,13(2):154~156.
[4] 王亚均.酚妥拉明联合多巴胺或西地兰治疗小儿重症肺炎合并心力衰竭的临床疗效对比研究[J].山西医药杂志,2015,19(24):2890~2892.
[5] 黄诚花,李林祖,张明真,等.不同剂量多巴胺联合多巴酚丁胺对重症肺炎患儿血清C反应蛋白、免疫球蛋白水平的影响[J].实用心脑肺血管病杂志,2017,22(5):160~162.
[6] 汪翼.儿科学[M].第5版.人民卫生出版社,2004.
[7] 蒋海珍.小剂量多巴胺联合多巴酚丁胺在重症肺炎患儿中的临床效果分析[J].中华全科医学,2016,14(1):90~92.
[8] 杨英.多巴胺联合多巴酚丁胺治疗小儿重症肺炎的疗效及对炎症因子的影响[J].中国妇幼保健,2014,29(35):5819~5821.
[9] 王晓瑜,刘小芸,蒋艳.多巴胺、多巴酚丁胺联合应用对小儿重症肺炎炎症因子及基质金属蛋白酶功能水平的影响[J].海南医学院学报,2016,22(3):270~272. |
|
|
|
2018, Vol. 24 
